Follow this preprint

Evolution of COVID-19 cases in selected low- and middle-income countries: have they peaked due to high levels of infection and immunity?

Axel S. Lexmond, Carlijn J.A. Nouwen, Othmane Fourtassi, J. Paul Callan
doi: https://doi.org/10.1101/2020.09.26.20201814
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2020.09.26.20201814
History 
  • October 12, 2020.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

REVISION SUMMARY

  • Removed Namibia from the selected LMICs, so that there are now 10 of them. We inadvertently used the wrong data for Namibia, and it should not have been included. Please refer to the [updated Oct-12] Supplementary materials (which is the appropriate version for this manuscript).

Author Information

  1. Axel S. Lexmond1,*,
  2. Carlijn J.A. Nouwen2,*,†,
  3. Othmane Fourtassi2 and
  4. J. Paul Callan2,*,†
  1. 1Department of Engineering, University of Pretoria, South Africa
  2. 2Personal capacity
  1. ↵†Corresponding authors., Email: nouwencarlijn{at}gmail.com (C.J.A.N.); paul_callan{at}post.harvard.edu (J.P.C.)

  1. ↵* These authors contributed equally to this work.

Back to top
Posted October 12, 2020.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Evolution of COVID-19 cases in selected low- and middle-income countries: have they peaked due to high levels of infection and immunity?
Axel S. Lexmond, Carlijn J.A. Nouwen, Othmane Fourtassi, J. Paul Callan
medRxiv 2020.09.26.20201814; doi: https://doi.org/10.1101/2020.09.26.20201814
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

2

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

3

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.